درباره این اپیزود
Not all genetic variations are associated with threats or harms to human health. Some even protect us, such as genetic variations that have been shown to make bones harder or the heart more impervious to disease. But while some genetic variations are positive, others can cause or contribute to disease.
In this episode, we answer the question of how does gene therapy work, and learn how gene therapy replaces and repairs certain gene variants, and is changing the trajectory of genetic diseases.
For several years, Dr. Jean Bennett at the University of Pennsylvania’s Department of Ophthalmology Center for Advanced Retinal and Ocular Therapeutics investigated the possibility of replacing gene variants in the retina – which cause blindness – with copies of healthy ones.
After successfully treating blind puppies, Dr. Bennett and her colleagues turned their attention to treating human eyesight.
The retina turned out to be a good target site for gene therapy. In most parts of the human body, our cells keep dividing after we’re born. But not the rods and cones in our retina – these photoreceptor cells don’t regenerate.
A major obstacle in the development of gene therapy is the tendency of cloned genes to get lost in the process of cell division before they have a chance to integrate into the host DNA. Because retinal cells don’t divide after birth, the cloned gene may be expressed for a prolonged time
In 2017, after decades of painstaking research, building on the efforts of countless scientists throughout history, Dr. Bennett and her colleagues had the evidence that gene therapy may be used to treat genetic conditions in humans.
Since then, gene therapy has undergone giant leaps in the treatment of specific diseases.
And record numbers of gene therapy trials are ongoing, including potential treatments for conditions such as sickle cell disease and Parkinson’s disease.
It’s just one of many ways that the field of gene therapy is poised to change the world in the years to come.
For more education on gene therapy, visit www.genetherapynetwork.com.
In this episode, we answer the question of how does gene therapy work, and learn how gene therapy replaces and repairs certain gene variants, and is changing the trajectory of genetic diseases.
For several years, Dr. Jean Bennett at the University of Pennsylvania’s Department of Ophthalmology Center for Advanced Retinal and Ocular Therapeutics investigated the possibility of replacing gene variants in the retina – which cause blindness – with copies of healthy ones.
After successfully treating blind puppies, Dr. Bennett and her colleagues turned their attention to treating human eyesight.
The retina turned out to be a good target site for gene therapy. In most parts of the human body, our cells keep dividing after we’re born. But not the rods and cones in our retina – these photoreceptor cells don’t regenerate.
A major obstacle in the development of gene therapy is the tendency of cloned genes to get lost in the process of cell division before they have a chance to integrate into the host DNA. Because retinal cells don’t divide after birth, the cloned gene may be expressed for a prolonged time
In 2017, after decades of painstaking research, building on the efforts of countless scientists throughout history, Dr. Bennett and her colleagues had the evidence that gene therapy may be used to treat genetic conditions in humans.
Since then, gene therapy has undergone giant leaps in the treatment of specific diseases.
And record numbers of gene therapy trials are ongoing, including potential treatments for conditions such as sickle cell disease and Parkinson’s disease.
It’s just one of many ways that the field of gene therapy is poised to change the world in the years to come.
For more education on gene therapy, visit www.genetherapynetwork.com.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
قسمت های دیگر در این پادکست
A young man calls his doctor – he has hemophilia and joint pain – he knows what this is, he’s had it before: it’s a knee bleed. He’s given himself three doses of blood clotting factor, but it’s not working. When he arrives at the hemophilia treatment center, his care team takes a closer look – and …
A young boy goes to urgent care, he’s fallen and his knee is swollen – likely a soft tissue trauma or at worst a minor joint bleed. He’s given a brace, told to rest. At follow up, everything is as expected – until a nurse reviews his chart and sees the child has hemophilia. We’re no longer talking …
Transitioning hemophilia care from pediatric to adult care sounds simple enough. At home, though, it can be complicated—habits run deep, and for parents of children with hemophilia, the line between protection and independence isn’t always clear. In this episode, we’ll explore how hemophilia treatm…
If you work in healthcare, you’ve felt it—that moment when communication breaks down. This season on DDx, we’re going inside hemophilia treatment centers—places where teamwork isn’t optional. It’s what holds everything together. You’ll hear stories from the people who do this work every day—how col…
A young man walks into a hemophilia treatment center. He’s limping, certain his ankle is bleeding again—same as always. But this time, the team discovers the pain may be coming from something else, something that isn’t in the patient’s chart. In this story, we explore the many ways and forms pain c…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به Figure 1 است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم